Interestingly, along with the rapid improvement in glucose-lipid metabolism and insulin resistance, and elevated plasma insulin, we observed a dramatic decrease in fasting plasma FGF-21 concentrations in these patients. The gene discussed is FGF21; the disease is Insulin resistance.